Treatment of cells with Pycnogenol decreased the activity of both TrxR and GPx in cells by more than 50%, but GR was not affected.. Addition of Pycnogenol after sele-nite treatment reduc
Trang 1systems in U1285 human lung carcinoma cells
Valentina Gandin1,*, Christina Nystro¨m1, Anna-Klara Rundlo¨f1, Kerstin Jo¨nsson-Videsa¨ter2,
Frank Scho¨nlau3, Jarmo Ho¨rkko¨4, Mikael Bjo¨rnstedt1and Aristi P Fernandes1
1 Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
2 Division of Haematology and Oncology, Department of Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden
3 Department of Pharmaceutical Chemistry, University of Mu¨nster, Germany
4 Almado, Turku, Finland
Oxidative stress is associated with many pathological
events, such as degenerative diseases, arteriosclerosis,
inflammatory diseases and cancer It is believed to be
due to an imbalance in the formation and degradation
of reactive oxygen species (ROS), e.g superoxide anion
(O2 )), hydroxyl radical (OH•)) and hydrogen peroxide
(H2O2) [1] ROS are highly reactive compounds derived
from oxygen, that in moderate amounts are needed for
intracellular signalling, redox regulation and as a
defence against infections However, as the intracellular
environment is normally reduced, an excessive amount
of ROS can react with and harm important parts of the cell such as DNA, proteins and lipids
Pycnogenol, a natural extract marketed as a food supplement or herbal drug, has been shown to have antioxidant and free radical scavenging activities [2] Pycnogenolis extracted from the bark of French mari-time pine (Pinus maritima), which grows in the coastal region of southwest France The main constituents are monomeric phenolic compounds (catechin, epicatechin and taxifolin) and condensed flavonoids (procyanidines and proanthocyanidines) These compounds are also
Keywords
antioxidant; glutathione peroxidise; oxidative
stress; Pycnogenol ; thioredoxin reductase
Correspondence
A P Fernandes, Division of Pathology,
Department of Laboratory Medicine,
Karolinska Institutet, Karolinska University
Hospital Huddinge, SE-14186 Stockholm,
Sweden
Fax: +46 8 58581020
Tel: +46 8 58582926
E-mail: aristi.fernandes@ki.se
*Permanent address
Department of Pharmaceutical Sciences,
University of Padova, Italy
(Received 29 August 2008, revised 15
October 2008, accepted 13 November
2008)
doi:10.1111/j.1742-4658.2008.06800.x
Pycnogenol, which is extracted from the bark of French maritime pine, has been shown to have antioxidant and free radical scavenging activities Thioredoxin reductase (TrxR), glutathione peroxidase (GPx) and glutathi-one reductase (GR) are three central redox enzymes that are active in endogenous defence against oxidative stress in the cell Treatment of cells with Pycnogenol decreased the activity of both TrxR and GPx in cells by more than 50%, but GR was not affected As previously reported, both enzymes were induced after treatment with hydrogen peroxide and selenite The presence of Pycnogenol efficiently decreased selenite-mediated reac-tive oxygen species (ROS) production Addition of Pycnogenol after sele-nite treatment reduced the mRNA expression and activity of TrxR to basal levels In contrast, the GPx activity was completely unaffected The dis-crepancy between TrxR and GPx regulation may indicate that transcription
of TrxR is induced primarily by oxidative stress As TrxR is induced in various pathological conditions, including tumours and inflammatory condi-tions, decreased activity mediated by a non-toxic agent such as Pycnogenol may be of great value
Abbreviations
DTNB, 5,5¢-dithiobis(2-nitrobenzoic acid); GPx, glutathione peroxidase; GR, glutathione reductase; ROS, reactive oxygen species; SeMC, Se-methyl-seleno- L -cysteine; tert-BuOOH, t-butyl hydroperoxide; Trx, thioredoxin; TrxR, thioredoxin reductase.
Trang 2important constituents of fruits, vegetables and other
plants [3] Pycnogenol has been shown to have
excel-lent radical scavenger and antioxidant properties in
model reactions that are superior to those of other fruit
and plant extracts and other antioxidants [2,3]
Pycno-genolhas no mutagen activity according to the Ames
test, and has low acute and chronic toxicity [2] In
addi-tion, Pycnogenol has been shown to protect DNA
against oxidative damage in vivo [4] Supplementation
with Pycnogenol has been shown to have beneficial
effects on patients with retinopathy, reducing retinal
microbleeding and oedema and improving vision [5]
Pycnogenol supplementation has also been shown to
improve endothelial function in hypertensive patients,
decreasing the hypertension [6], and to lower glucose
levels in type 2 diabetic patients [7]
Thioredoxin reductase (TrxR), glutathione
peroxi-dase (GPx) and glutathione reductase (GR) are three
important redox enzymes in the endogenous defence
against oxidative stress As ROS are continuously
formed in all aerobic organisms during metabolism,
there is a need for effective defence systems that
scav-enge the excessive amounts of ROS Apart from being
important in the defence against ROS, TrxR and GPx
are selenium-containing enzymes [8] Because it is part
of important redox enzymes such as GPx and TrxR,
selenium is an essential trace element, and considered a
physiological antioxidant [9] At low to moderate
con-centrations, selenium is known to induce the expression
of several selenoenzymes, including TrxR and GPx [10]
The biological effects of selenium are however strictly
concentration-dependent, with antioxidant properties at
low concentrations and powerful pro-oxidant effects at
moderate to high concentrations
TrxR, together with thioredoxin (Trx) and NADPH,
comprises an important defence system against
oxida-tive stress, named the thioredoxin system [11,12] Trx
is a small ubiquitous protein with a redox-active
disul-fide⁄ dithiol that reduces disulfides, which is important
in many redox-regulated reactions TrxR is an essential
protein that not only reduces Trx but also many other
substrates such as selenium compounds [12] and Q10
[13] Mammalian thioredoxin reductases are
oxido-reductase flavoproteins, with a C-terminal active site
with a conserved GCUG sequence [14,15] that is
neces-sary for catalytic activity [16,17] Three mammalian
genes for TrxR have previously been identified The
first is the ‘classical’ cytosolic TrxR1 [18], with five
potential isoforms that differ at the C-terminal The
other two, a mitochondrial and a
glutaredoxin-containing thioredoxin reductase, are named TrxR2
and TGR, respectively [19–22] The thioredoxin system
is involved in many biological processes, such as DNA
synthesis, apoptosis and regulation of several transcrip-tion factors [23] Furthermore, it is known that thiore-doxin family proteins are induced in several tumors, and the thioredoxin system is thus suggested to be a prime target in cancer therapy [24–26]
The aim of this study was to investigate the antioxi-dant effects of Pycnogenol on redox enzymes, with emphasis on the regulation of TrxR
Results
Effects of Pycnogenolon cellular TrxR enzyme activity
To investigate the effects of Pycnogenolon the TrxR, GPx and GR activity, the cells were cultivated for 48 h supplemented with various concentrations of Pycno-genol up to 25 lgÆmL)1 (Fig 1A–C) The applied doses of Pycnogenol (1–25 lgÆmL)1) did not signifi-cantly affect cell viability (Table 1) Cells were har-vested and homogenized and the enzyme activity was determined Pycnogenol treatment decreased the activity of both TrxR and GPx in cells by more than 50% compared to control cells, but the effect was less pronounced for GPx compared to TrxR (Fig 1) In contrary to the selenoenzymes TrxR and GPx, Pycno-genol did not affect the enzyme activity of GR (Fig 1C) The reduction of TrxR and GPx activity was dose-dependent, with maximal effects achieved at concentrations of Pycnogenol of 15 lgÆmL)1 for TrxR and 25 lgÆmL)1for GPx (Fig 1)
Time-dependent effects of Pycnogenol The time-dependent effect of Pycnogenol was inves-tigated by cultivating U1285 cells with 25 lgÆmL)1 Pyc-nogenol for 5 days Cells were harvested at various time points, and the TrxR and GPx enzyme activity was measured (Fig 2A,B) No time-dependent effects were observed, as the activity of both enzymes decreased in parallel with the duration of incubation for both treated and non-treated cells, reflecting varying expression at the various stages of the cell cycle The presence of Pyc-nogenol(25 lgÆmL)1) resulted in a remarked decrease
in activity at all time points (Fig 2)
Dose-dependent effects of Pycnogenolon TrxR enzyme activity in vitro
To determine any direct inhibition of Pycnogenol on TrxR enzyme activity, purified TrxR1 was incubated with Pycnogenol at various concentrations (up to
100 lgÆmL)1) and for various durations (0, 5, 10, 15
Trang 3and 30 min), and analysed spectrophotometrically.
There was, however, no significant effect of
Pycnoge-nol on pure TrxR1 enzyme activity (data not shown)
Effects on the viability of U1285 cells The toxicity of the compounds used was assessed by means of determination of the IC50 value for each compound using a viability assay (Table 1) As shown
in Table 1, the IC50 of Pycnogenol was first reached
at doses exceeding 500 lgÆmL)1 This clearly
demon-A
B
C
Fig 1 Levels of activity after treatment with Pycnogenol in
U1285 cells Activity of (A) TrxR, (B) GPx and (C) GR in U1285 cell
homogenates treated for 48 h with increasing concentrations of
Pycnogenol (0–25 lgÆmL)1) Error bars represent the standard
error based on at least three independent experiments.
A
B
Fig 2 TrxR and GPx activity in U1285 cell homogenates after treatment with Pycnogenol for various time periods (A) TrxR activity; (B) GPx activity White bars indicate controls treated with
25 m M Hepes in NaCl ⁄ P i Black bars indicate cells treated with
25 lgÆmL)1Pycnogenol Error bars represent the standard error based on at least three independent experiments.
Table 1 IC 50 values of various compounds in U1285 cells.
Se-methyl-seleno- L -cysteine > 500 l M
tert-butyl hydroperoxide 341.58 ± 9.75 l M
a
IC 50 values were calculated by probit analysis (P < 0.05; v2test).
Trang 4strates that the antioxidant properties of Pycnogenol
(1–10 lgÆmL)1) occur at concentrations far lower than
the toxic dose
ROS production
To further explore the antioxidant effect of
Pycnoge-nol, production of peroxide was measured in cells after
treatment with 10 lgÆmL)1Pycnogenolin combination
with either selenite, Se-methyl-seleno-l-cysteine (SeMC)
or tert-butyl hydroperoxide (tert-BuOOH) (Fig 3) at
doses marginally affecting cell viability These
com-pounds are all known to cause oxidative stress, which is
also shown in Fig 3 Pycnogenolwas able to efficiently
decrease ROS production by all compounds tested
Effect of Pycnogenolon cellular TrxR and GPx
activity during oxidative stress
To investigate the mechanisms of Pycnogenol on
TrxR and GPx enzyme activity, the cells were exposed
to oxidative stress in the form of H2O2 The cells were
first incubated with Pycnogenol for 48 h, followed by
H2O2 treatment at a concentration of 0.1 mm and
incubation for an additional 48 h Then the cells were
harvested and homogenized and the enzyme activity
was measured Inhibition of enzyme activity of
Pycno-genol in control cells is evident for both TrxR and GPx (Fig 4) The activity of TrxR was highly increased after exposure to oxidative stress compared
to the control as shown in Fig 4A However, the increase was reversible for TrxR after addition of
25 lgÆmL)1 Pycnogenol, declining to the basal level GPx, on the other hand, barely responded to treatment with hydrogen peroxide, and Pycnogenol did not lower GPx activity in the presence of hydrogen perox-ide (Fig 4B)
Fig 3 Determination of ROS production ROS production was
detected using CM-H2DCFDA after 8 h treatment with 10 lgÆmL)1
Pycnogenol alone or in combination with 7.5 l M selenite (Se),
500 l M Se-methyl-seleno- L -cysteine (SeMC), 750 l M tert-butyl
hydroperoxide (tert-BuOOH) or 40 l M rotenone (positive control).
Error bars represent the standard error based on three independent
experiments The Wilcoxon matched-pair test was used to
compare effects between control ⁄ treatment experimental set-ups:
**P < 0.01; ***P < 0.001.
A
B
Fig 4 TrxR and GPx activity after treatment with Pycnogenolin combination with hydrogen peroxide (A) TrxR activity and (B) GPx activity in cell homogenates pre-treated with 25 lgÆmL)1 Pycnoge-nolfor 24 h, followed by treatment with or without 0.1 m M H 2 O 2
for an additional 48 h Black bars indicate the addition of 0.1 m M
H2O2 Error bars represent the standard error based on three inde-pendent experiments The Wilcoxon matched-pair test was used to compare effects between control ⁄ treatment experimental set-ups:
*P < 0.05; **P < 0.01; ***P < 0.001.
Trang 5Effect of Pycnogenol on cellular TrxR and GPx
activity after treatment with selenite
As previously reported [27], both TrxR and GPx
activ-ity were elevated after selenite treatment (Fig 5) In
contrast to GPx, TrxR was clearly affected by the
addition of Pycnogenol, while GPx remained high
activity following selenite treatment even after addition
of Pycnogenol(Fig 5B)
TrxR1 protein levels and TrxR1/TrxR2 mRNA
expression
As the TrxR activity was remarkably upregulated by
both selenite and hydrogen peroxide, with a reversible
affect after treatment with Pycnogenol, the protein and
mRNA expression were investigated TrxR1 protein
lev-els decreased remarkably, corresponding to the drop in activity A significant decrease in mRNA expression was seen for both enzymes after treatment with 5 lgÆmL)1 Pycnogenolalone (Fig 6) Moreover, the same pattern with a decrease, as in mRNA expression was seen for the activity when treated in combination with either sel-enite or tert-BuOOH The effect on TrxR1 mRNA was nevertheless much more pronounced compared to TrxR2
Discussion
Pycnogenol has a wide variety of highly interesting effects, including anti-inflammatory properties, benefi-cial effects on the vascular system, and protection from
UV radiation [2] Furthermore, Pycnogenol is an extremely efficient antioxidant, and it is likely that many of its effects may be explained by its antioxidant action The antioxidant effects of Pycnogenol are fur-ther supported by our finding that Pycnogenol decreases the production of hydrogen peroxide when added in combination with compounds known to pro-duce ROS, including selenite (Fig 3) Even though our findings are based on use of a lung carcinoma cell line,
we strongly believe that the action of Pycnogenol is a general mechanism and not only applicable in our model cell system, as the antioxidant effects of Pycno-genol have been explored in other cell lines by us (data not shown) and also described by others [2,3] The antioxidant effects of Pycnogenol clearly resulted in a decrease in protein expression together with
a reduction in the cellular activity of TrxR The effect
on GPx was much less pronounced, but still showed a slight inhibition The decrease in enzyme activity could however not be explained by direct inhibition of TrxR,
as in vitro experiments with pure TrxR1 and Pycnoge-noldid not result in any inhibitory effect Mammalian TrxRs are complex selenoenzymes with many physiolog-ical functions, including reduction of thioredoxin and other low molecular weight substances, and reduction and detoxification of hydroperoxides [9] This reduction may be direct or by regeneration of antioxidants includ-ing Q10, vitamin C and lipoic acid [13,28] Another important function is to reduce selenium compounds, thereby providing active selenide for the synthesis of selenoproteins [29,30] Our data show that addition of hydrogen peroxide led to increased enzyme activity, indicating that TrxR is regulated by the redox state of the cell Furthermore, hydrogen peroxide could in part prevent the effect of Pycnogenol and thus partly restore the activity of TrxR One possible mechanism explaining the effect of Pycnogenol on the activity of TrxR is that Pycnogenolis an extremely efficient anti-oxidant that changes the redox status of the cell, thus
Fig 5 TrxR and GPx activity after treatment with Pycnogenolin
combination with selenite (A) TrxR activity and (B) GPx activity in
U1285 cell homogenates treated with Pycnogenol alone
(25 lgÆmL)1) or in combination with 5 l M selenite for 48 h Black
bars indicate the addition of selenite Error bars represent the
stan-dard error based on three independent experiments The Wilcoxon
matched-pair test was used to compare effects between
control ⁄ treatment experimental set-ups: *P < 0.05; **P < 0.01.
Trang 6removing a stimulus for the synthesis of TrxR
How-ever, Pycnogenoldid not suppress TrxR1 to sub-basal
levels As shown in the ROS production experiment,
Pycnogenol completely reversed the ROS formation
induced by both selenite and tert-BuOOH However,
the activity of GPx was barely affected by the addition
of hydrogen peroxide after 48 h, implying a different
response to oxidative stress to that seen for TrxR
Both TrxR and GPx are selenoproteins that are
known to be regulated by the selenium content in the
cell, with selenium generating a maximum expression
level for TrxR and GPx at around 1 lm However,
TrxR1 is more readily saturated than GPx in response
to selenium supplementation [31], probably due to the
higher ranking of TrxR1 in terms of the hierarchy of
selenoenzymes [32] Treatment of cells with an organic
selenium compound, SeMC, did not cause any cell
death even at very high concentrations SeMC is a
natural selenium compound that is cleaved by b-lyase
to highly redox-active monomethyl selenol [33]
How-ever, in the absence of b-lyase, monomethyl selenol is
not formed, explaining the low toxicity of SeMC in
U1285 cells Despite the low cytotoxicity, SeMC caused
increased ROS production in the cells By using an
inorganic selenium compound such as selenite as an
oxidative agent, the regulation of expression of the
anti-oxidant selenoproteins becomes much more complex
We show here that regulation of TrxR appears to be primarily dependent on the redox state of the cell, rather than the selenium content This is demonstrated
by the effect of addition of Pycnogenol after selenite treatment, which decreases the activity of TrxR to levels below those of untreated cells, even though sele-nite alone resulted in a higher response compared to treatment with hydrogen peroxide This was not the case for GPx activity, which, although it was consider-ably elevated after selenite treatment, was not at all affected by addition of Pycnogenol These findings are interesting and unexpected, as both enzymes have strong antioxidant properties and are dependent on selenium bioavailability The decreased enzyme activity and mRNA expression of TrxR caused by Pycnogenol alone and in combination with oxidants also gives an insight in the complex regulation of TrxR These observations indicate that there is a defined hierarchy
at various regulatory levels The antioxidant-response elements in the promoter region of TrxR, which are targeted by nuclear erythroid-2-related factor (Nrf2) [34], are probably one of the most important regulatory elements for TrxR Although our data suggest an effect
of Pycnogenol primarily at the transcription level, effects on translation may also occur One example is the strictly redox-regulated translation factor SBP2, which is required for incorporation of selenocycstein
A
B
Fig 6 Protein levels of TrxR1 and TrxR1 ⁄
TrxR2 mRNA expression in the U1285 cell
line (A) Western blot comparing TrxR1
protein levels after treatment of cells for
48 h with Pycnogenol (25 lgÆmL)1)
Poly-clonal TrxR1 antibodies are known to
generate more than one band due to the
existence of several protein isoforms.
(B) TrxR1 (black bars) and TrxR2 (grey bars)
mRNA levels after treatment with 5 or
10 lgÆmL)1Pycnogenol alone or in
combination with 5 l M selenite or 250 l M
tert-BuOOH for 48 h Error bars represent
the standard error based on three
indepen-dent experiments The Wilcoxon
matched-pair test was used to compare effects
between control ⁄ treatment experimental
set-ups: *P < 0.05; **P < 0.01;
***P < 0.001.
Trang 7into selenoproteins SBP2 is translocated to the nucleus
when oxidized, resulting in translational inhibition of
TrxR [8] The less pronounced effects seen for TrxR2
may be explained by the localization of TrxR2 in the
mitochondria, which may be slightly less affected than
the cytosol under these conditions As TrxR is induced
in various pathological conditions, including tumours
and inflammatory conditions [35], decreased activity
mediated by a non-toxic agent such as Pycnogenol
would be beneficial, and may offer a mechanistic
expla-nation for the effects of Pycnogenol
Experimental procedures
Chemicals
5,5¢-dithiobis(2-nitrobenzoic acid) (DTNB), guanidine HCl,
sodium deoxycholate, sodium selenite, glutathione, GPx
from bovine erythrocytes, insulin from bovine pancreas, and
NADPH were all purchased from Sigma (St Louis, MO,
USA) Baker’s yeast GR was obtained from Fluka (Buchs,
Switzerland), Escherichia coli Trx1 was purchased from
Pro-mega, and recombinant rat TrxR1 was generously provided
by Elias Arne´r (Department of MBB, Karolinska Institutet,
Stockholm, Sweden) Pycnogenol was kindly provided by
Horphag Research Ltd (Geneva, Switzerland)
Se-methyl-seleno-l-cysteine (SeMC) was purchased from PharmaSe
(Lubbock, TX, USA)
Cell line
The cells (U1285, a small-cell lung carcinoma cell line [36])
were cultured in RPMI-1640 medium with GlutaMAX-1
and 25 mm Hepes (Invitrogen, Paisley, UK), supplemented
with 10% heat-inactivated fetal bovine serum The cells
were maintained in a humidified incubator with 5% CO2at
37C The cells were cultured in the presence of indicated
concentrations of Pycnogenol for various time periods
The Pycnogenolpowder was solved in NaCl⁄ Picontaining
25 mm Hepes The effect of Pycnogenol was also studied
in combination with selenite, SeMC, tert-butyl
hydroper-oxide (tert-BuOOH) and H2O2 Selenite, SeMC or
tert-BuOOH, was added together with Pycnogenol, while
H2O2was added after 48 h of Pycnogenolpre-treatment
Preparation of cell homogenates
Buffer (50 mm Tris⁄ HCl pH 7.6 and 1 mm EDTA) was
added to the cell pellet, after which it was kept on ice The
cells were sonicated three times for 15 seconds, followed by
centrifugation at 25 200 g for 10 min at 2C The
super-natants were stored at)20 C for later enzyme activity
stu-dies The protein concentrations in the cell homogenates
were determined by the Biuret method [37]
TrxR enzyme activity assay The activity of the TrxR enzyme was measured through a coupled reaction in the cell homogenates essentially as described previously [38] From each homogenate, 200 lg proteins were incubated with 80 mm Hepes (pH 7.5), 0.9 mgÆmL)1NADPH, 6 mm EDTA, 2 mgÆmL)1insulin and
10 lm E coli Trx at 37C for 20 min in a final volume of
120 lL The reaction was terminated by addition of 500 lL DTNB (0.4 mgÆmL)1) with 6 m guanidine HCl in 0.2 m Tris⁄ HCl pH 8.0 The absorbance at 412 nm was measured using a SpectraMax 250 (Molecular Devices, Sunnyvale, CA, USA) within 20 min To determine the effects of Pycnoge-nolon pure TrxR1, 10 nm recombinant rat TrxR1 was used instead of the homogenate, with the addition of only 5 lm
E coliTrx1
GR enzyme activity assay Determination of the GR enzyme activity was performed as for the TrxR1 enzyme activity except that insulin was replaced by 1 mm oxidized glutathione, and 10 lg of protein was incubated for each sample
GPx enzyme activity assay The GPx enzyme activity was measured through a coupled reaction as described previously [39] A modified protocol was created to fit a 96-well plate For each cell homoge-nate, 200 lg of protein was incubated for 3 min at 25C with 0.1 m Tris⁄ HCl buffer (pH 7.6), 2 mm EDTA, 2 mm NaN3, 4 mm glutathione, 10 units of GR and 0.8 mm NADPH in a total volume of 195 lL After incubation,
H2O2 was added to a final concentration of 10 mm as substrate for the GPx, and the absorbance at 340 nm was recorded
Viability assay
In order to investigate the susceptibility of the cells to treatment with the various compounds, a Cell Prolifera-tion Kit II (XTT) from Roche Diagnostics (Mannheim, Germany) was used Estimated IC50 values from these trials were used to decide an appropriate range of con-centrations for treatment in all experiments conducted The viability assay was performed in 96-well flat-bot-tomed culture dishes with 100 lL medium⁄ well at approximately 10% cell confluence Cells were subjected
to treatment for 48 h, followed by an incubation time of
4 h before measurement Absorbance was measured at
490 nm (with a reference wavelength of 650 nm sub-tracted) using a SpectraMax 250 All samples were measured in triplicate, and the entire assay was repeated three times
Trang 8ROS production
Intracellular ROS production was detected using
non-fluorescent compound
5(6)-chloromethyl-2¢,7¢-dichlorodihy-drofluorescein diacetate (CM-H2DCFDA) (Invitrogen)
CM-H2DCFDA undergoes deacetylation by intracellular
esterases, and the product quantitatively reacts with oxygen
species inside the cell to produce the fluorescent dye
5(6)-carboxy-2¢,7¢-dichlorofluorescein (CM-DCF) Briefly,
U1285 cells (104per well) were grown for 24 h in a 96-well
plate in RPMI-1640 without phenol red Subsequently, the
medium was removed and the cells were incubated for
45 min in the dark with 10 lm CM-DCFDA in NaCl⁄ Pi
Excess probe was washed out with NaCl⁄ Pi, and cells were
incubated with the reported concentrations of tested
com-pounds for 8 h The increase in fluorescence was
deter-mined at wavelengths of 485 nm (excitation) and 527 nm
(emission) on a SpectraMax 250
Western blotting
Samples were analysed on 7.5% SDS–PAGE at 150 V,
followed by semi-dry electroblotting to a nitrocellulose
mem-brane for 1 h at 100 V Memmem-branes were probed with
anti-TrxR1 (1 : 2000, Upstate, Lake Placid, NY, USA) and
incubated for 1 h at room temperature The membranes were
further incubated with a horseradish peroxidase-conjugated
secondary antibody (1 : 3000, DakoCytomation, Glostrup,
Denmark) Bound antibodies were detected using a
chemilu-minescence Western Lightning kit (PerkinElmer, Boston,
MA, USA) according to the manufacturer’s instructions
Real-time PCR
Total RNA was isolated using and RNeasy mini kit (Qiagen,
Hilden, Germany), according to the manufacturer’s
proto-col RNA quantification was performed using a Ribogreen
RNA quantification kit (Molecular Probes, Eugene, OR,
USA) according to the supplied ‘high range’ protocol with
rRNA as the standard Synthesis of cDNA was performed
by reverse transcription of 2 lg of RNA using the
Omni-script reverse tranOmni-scription kit (Qiagen) with oligo(dT)12–18
as primer (final concentration 0.1 lgÆlL)1) Real-time
quan-titative PCR was performed on a Bio-Rad ICycler (Bio-Rad,
Hercules, CA, USA) with 20 ng of cDNA per reaction in
triplicate on 96-well plates using Platinum SYBR Green
qPCR super mix (Invitrogen) Determination of TrxR1
mRNA levels was performed as described previously [40]
TrxR2 mRNA was analyzed using the same program as for
TrxR1 but with forward primer 5¢-TCAGAAGATCC
TGGTGGACTCC-3¢ and reverse primer 5¢-TCGTGGG
AACATTGTCGTAGTC-3¢, with concentration of 300 nm
for each primer The results were analysed using the 2 DDC t
method The CTvalue cut-off was set at 32 cycles The
effi-ciency of the primer sets was 90 ± 5%
Acknowledgements
This investigation was supported by Radiumhemmets Research Society, Horphag Research Ltd, the Swedish Medical Association, Karolinska Institutet Research Grants, and the Swedish Cancer Society
References
1 Nordberg J & Arne´r ES (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system Free Radic Biol Med 31, 1287–1312
2 Rohdewald P (2002) A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology Int J Clin Phar-macol Ther 40, 158–168
3 Packer L, Rimbach G & Virgili F (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol Free Radic Biol Med 27, 704–724
4 Rohdewald P (2005) Pycnogenolprotects DNA against oxidative damage in vivo Phytother Res 19, 262
5 Spadea L & Balestrazzi E (2001) Treatment of vascular retinopathies with Pycnogenol Phytother Res 15, 219– 223
6 Liu X, Wei J, Tan F, Zhou S, Wurthwein G & Rohde-wald P (2004) Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients Life Sci 74, 855–862
7 Liu X, Zhou HJ & Rohdewald P (2004) French maritime pine bark extract Pycnogenoldose-dependently lowers glucose in type 2 diabetic patients Diabetes Care 27, 839
8 Papp LV, Lu J, Holmgren A & Khanna KK (2007) From selenium to selenoproteins: synthesis, identity, and their role in human health Antioxid Redox Signal
9, 775–806
9 Bjo¨rnstedt M, Hamberg M, Kumar S, Xue J & Holmgren
A (1995) Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically gener-ated selenols J Biol Chem 270, 11761–11764
10 Gladyshev VN & Kryukov GV (2001) Evolution of sel-enocysteine-containing proteins: significance of identifi-cation and functional characterization of selenoproteins Biofactors 14, 87–92
11 Arne´r ES & Holmgren A (2000) Physiological functions
of thioredoxin and thioredoxin reductase Eur J Bio-chem 267, 6102–6109
12 Bjo¨rnstedt M, Kumar S, Bjo¨rkhem L, Spyrou G & Holmgren A (1997) Selenium and the thioredoxin and glutaredoxin systems Biomed Environ Sci 10, 271–279
13 Xia L, Nordman T, Olsson JM, Damdimopoulos A, Bjo¨rkhem-Bergman L, Nalvarte I, Eriksson LC, Arne´r
ES, Spyrou G & Bjo¨rnstedt M (2003) The mammalian cytosolic selenoenzyme thioredoxin reductase reduces
Trang 9ubiquinone A novel mechanism for defense against
oxidative stress J Biol Chem 278, 2141–2146
14 Gladyshev VN, Jeang KT & Stadtman TC (1996)
Selen-ocysteine, identified as the penultimate C-terminal
resi-due in human T-cell thioredoxin reductase, corresponds
to TGA in the human placental gene Proc Natl Acad
Sci USA 93, 6146–6151
15 Tamura T & Stadtman TC (1996) A new selenoprotein
from human lung adenocarcinoma cells: purification,
properties, and thioredoxin reductase activity Proc Natl
Acad Sci USA 93, 1006–1011
16 Zhong L, Arne´r ES, Ljung J, Aslund F & Holmgren A
(1998) Rat and calf thioredoxin reductase are
homolo-gous to glutathione reductase with a carboxyl-terminal
elongation containing a conserved catalytically active
penultimate selenocysteine residue J Biol Chem 273,
8581–8591
17 Zhong L & Holmgren A (2000) Essential role of
sele-nium in the catalytic activities of mammalian
thioredox-in reductase revealed by characterization of
recombinant enzymes with selenocysteine mutations
J Biol Chem 275, 18121–18128
18 Holmgren A (1977) Bovine thioredoxin system
Purifica-tion of thioredoxin reductase from calf liver and thymus
and studies of its function in disulfide reduction J Biol
Chem 252, 4600–4606
19 Spyrou G, Enmark E, Miranda-Vizuete A &
Gustafs-son J (1997) Cloning and expression of a novel
mam-malian thioredoxin J Biol Chem 272, 2936–2941
20 Damdimopoulos AE, Miranda-Vizuete A, Treuter E,
Gustafsson JA & Spyrou G (2004) An alternative
splic-ing variant of the selenoprotein thioredoxin reductase is
a modulator of estrogen signaling J Biol Chem 279,
38721–38729
21 Sun QA, Zappacosta F, Factor VM, Wirth PJ,
Hatfield DL & Gladyshev VN (2001) Heterogeneity
within animal thioredoxin reductases Evidence for
alternative first exon splicing J Biol Chem 276, 3106–
3114
22 Lescure A, Gautheret D, Carbon P & Krol A (1999)
Novel selenoproteins identified in silico and in vivo by
using a conserved RNA structural motif J Biol Chem
274, 38147–38154
23 Gromer S, Urig S & Becker K (2004) The
thioredox-in system – from science to clthioredox-inic Med Res Rev 24,
40–89
24 Powis G & Kirkpatrick DL (2007) Thioredoxin
signal-ing as a target for cancer therapy Curr Opin Pharmacol
7, 392–397
25 Urig S & Becker K (2006) On the potential of
thiore-doxin reductase inhibitors for cancer therapy Semin
Cancer Biol 16, 452–465
26 Nguyen P, Awwad RT, Smart DD, Spitz DR & Gius D
(2006) Thioredoxin reductase as a novel molecular
target for cancer therapy Cancer Lett 236, 164–174
27 Spyrou G, Bjo¨rnstedt M, Skog S & Holmgren A (1996) Selenite and selenate inhibit human lymphocyte growth via different mechanisms Cancer Res 56, 4407–4412
28 Arne´r ES, Nordberg J & Holmgren A (1996) Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase Biochem Biophys Res Commun
225, 268–274
29 Kumar S, Bjo¨rnstedt M & Holmgren A (1992) Selenite
is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxida-tion of NADPH in the presence of oxygen Eur J Bio-chem 207, 435–439
30 Bjo¨rnstedt M, Kumar S & Holmgren A (1992) Seleno-diglutathione is a highly efficient oxidant of reduced thi-oredoxin and a substrate for mammalian thithi-oredoxin reductase J Biol Chem 267, 8030–8034
31 Reeves PG, Leary PD, Gregoire BR, Finley JW, Lind-lauf JE & Johnson LK (2005) Selenium bioavailability from buckwheat bran in rats fed a modified AIN-93G torula yeast-based diet J Nutr 135, 2627–2633
32 Berry MJ (2005) Insights into the hierarchy of selenium incorporation Nat Genet 37, 1162–1163
33 Suzuki KT, Doi C & Suzuki N (2006) Metabolism of 76Se-methylselenocysteine compared with that of 77Se-selenomethionine and 82Se-selenite Toxicol Appl Pharmacol 217, 185–195
34 Hintze KJ, Wald KA, Zeng H, Jeffery EH & Finley JW (2003) Thioredoxin reductase in human hepatoma cells
is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element
J Nutr 133, 2721–2727
35 Becker K, Gromer S, Schirmer RH & Muller S (2000) Thioredoxin reductase as a pathophysiological factor and drug target Eur J Biochem 267, 6118–6125
36 Bjo¨rkhem-Bergman L, Jonsson K, Eriksson LC, Olsson
JM, Lehmann S, Paul C & Bjo¨rnstedt M (2002) Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity Effects on thioredoxin reductase and glutathione reductase Biochem Pharmacol 63, 1875–1884
37 Gornall AG, Bardawill CJ & David MM (1949) Deter-mination of serum proteins by means of the biuret reac-tion J Biol Chem 177, 751–766
38 Holmgren A & Bjo¨rnstedt M (1995) Thioredoxin and thioredoxin reductase Methods Enzymol 252, 199–208
39 Lawrence RA & Burk RF (1976) Glutathione peroxi-dase activity in selenium-deficient rat liver Biochem Biophys Res Commun 71, 952–958
40 Rundlo¨f AK, Fernandes AP, Selenius M, Babic M, Shariatgorji M, Nilsonne G, Ilag LL, Dobra K & Bjo¨rnstedt M (2007) Quantification of alternative mRNA species and identification of thioredoxin reduc-tase 1 isoforms in human tumor cells Differentiation
75, 123–132